Caffeine Completed Phase 2 / 3 Trials for Caffeine (DB00201)

Also known as: Caffeine measurement / Blood caffeine

IndicationStatusPhase
DBCOND0032271 (Caffeine)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03556917The Effects of Iontophoresis in Women With Gynoid Hidrolipodystrophy.Treatment